NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

ALPS Medical Breakthroughs ETF logo
$50.95 -1.58 (-3.01%)
Closing price 11/20/2026 04:10 PM Eastern
Extended Trading
$50.94 -0.01 (-0.01%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Advanced

Key Stats

Today's Range
$50.87
▼
$52.87
50-Day Range
$50.12
▼
$63.73
52-Week Range
$45.65
▼
$70.85
Volume
62,223 shs
Average Volume
37,255 shs
Market Capitalization
$170.68 million
Assets Under Management
$176.07 million
Dividend Yield
N/A
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

ALPS Medical Breakthroughs ETF Expenses

TypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.55%0.57%0.50%0.53%
Other Expenses0.00%0.52%0.53%0.60%0.54%
Total Expense0.50%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.76%-0.67%
Net Expense0.50%0.58%0.63%0.57%0.60%
Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBIO ETF News Headlines

ALPS Medical Breakthroughs ETF (SBIO)
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
SBIO: Promising Pipelines, Insufficient Return Potential
SBIO: Big Pharma Needs What This Fund Owns
(SBIO) ALPS Medical Breakthroughs ETF
See More Headlines

SBIO ETF - Frequently Asked Questions

ALPS Medical Breakthroughs ETF's stock was trading at $51.22 on January 1st, 2026. Since then, SBIO shares have decreased by 0.5% and is now trading at $50.95.

ALPS Medical Breakthroughs ETF's top institutional shareholders include Connors Investor Services Inc. (1.42%), HighTower Advisors LLC (1.22%), Fig Financial Advisory Services Inc. ADV (0.86%) and Virtu Financial LLC (0.82%).

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Walmart (WMT), Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Keysight Technologies (KEYS) and Block (XYZ).

Fund Details

Issuer
ALPS
Fund Name
ALPS Medical Breakthroughs ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:SBIO
Inception Date
12/30/2014
Fund Manager
Ryan Mischker, Andrew Hicks
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S-Network Medical Breakthroughs Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Constituents
106

Fund Statistics

Assets Under Management
$176.07 million
Average Daily Volume
$26.71 thousand
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
ALPS Fund Services, Inc.
Advisor
ALPS Advisors, Inc.
Custodian
State Street Bank and Trust Company
Distributor
ALPS Distributors, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
N/A
Short Interest
9,470 shs

Miscellaneous

Beta
0.79
Creation Unit
50,000
Creation Fee
$500.00
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Top 10 SBIO Holdings

SBIO Sector Exposure

SBIO Industry Exposure


This page (NYSEARCA:SBIO) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners